Mash Group Plc today announced audited consolidated results for the twelve months ending 31 December 2018.
- Revenue grew by 110% to EUR 34.5 million, EBIT grew by 221% to EUR 12.5 million and we generated a net profit
TOKYO, April 05, 2019 (GLOBE NEWSWIRE) — AnGes, Inc., a biopharmaceutical company focused on developing innovative gene-based medicines for treating serious diseases, announced today that they have obtained conditional approval (“Approval with Conditions and Time Limit”) from the Japanese Ministry
STATE DEPARTMENT The United States is acknowledging that many countries are not heeding warnings about the possible security risks in allowing Chinese tech giant Huawei to build the next generation of high-speech wireless networks known as 5G.
The trend is …
TAIPEI China is withholding details on the boundaries of its vast claims to a resource-rich sea contested by five other governments because it distrusts international law and wants to ensure control over tracts of water that it considers crucial, maritime …